Want to join the conversation?
$AMGN 2Q15 PR: Total revenues increased 4% versus 2Q14 to $5,370MM, with 6% product sales growth driven primarily by Enbrel, Prolia, Sensipar, Kyprolis and XGEVA. GAAP net income was $1,653MM compared to $1,547MM in 2Q14. GAAP EPS was $2.15 compared to $2.01 in 2Q14.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.